Andrea Harzstark
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC) (NCT01616186) | Andrea Harzstark | 2012-07-01 |
Track Andrea Harzstark automatically
Every clearance here is in the API, with alerts when new ones post.